Mesoblast (FRA:LWB) Other Operating Expense : €0.00 Mil (TTM As of Dec. 2024)

View and export this data going back to 2006. Start your Free Trial

What is Mesoblast Other Operating Expense?

Mesoblast's Other Operating Expense for the three months ended in Dec. 2024 was €0.00 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Dec. 2024 was €0.00 Mil.

Mesoblast's annual Other Operating Expense declined from Jun. 2022 (€0.51 Mil) to Jun. 2023 (€-3.24 Mil) but then increased from Jun. 2023 (€-3.24 Mil) to Jun. 2024 (€-0.76 Mil).

Mesoblast Other Operating Expense Historical Data

The historical data trend for Mesoblast's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mesoblast Other Operating Expense Chart

Mesoblast Annual Data

Trend

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Jun24

Other Operating Expense

Get a 7-Day Free Trial

-0.07

-1.30

0.51

-3.24

-0.76

Mesoblast Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Other Operating Expense	Get a 7-Day Free Trial															-	-	-	-	-

Mesoblast Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.00 Mil.

Mesoblast Other Operating Expense Related Terms

Thank you for viewing the detailed overview of Mesoblast's Other Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Mesoblast Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Mesoblast Ltd (FRA:LWB) » Definitions » Other Operating Expense

Comparable Companies

Traded in Other Exchanges

MEOBF:USA MESO:USA LWB:Germany MSB:Australia

Address

55 Collins Street, Level 38, Melbourne, VIC, AUS, 3000

Website

https://www.mesoblast.com

Mesoblast Ltd is a biotechnology company. It uses its proprietary technology platform to develop and commercialize allogeneic cellular medicines to treat complex diseases resistant to conventional standards of care and where inflammation plays a central role. The company's product candidates include; Ryoncil (remestemcel-L) for the treatment of steroid refractory acute graft versus host disease as well as for the treatment of moderate to severe acute respiratory distress syndrome; Revascor (rexlemestrocel-L) for the treatment of chronic heart failure; and Rexlemestrocel-L for chronic low back pain. The company is managed as one operating segment, being the development of cell technology platform for commercialization.

Mesoblast Headlines

No Headlines